Microsatellite Instability

Microsatellite instability (MSI) is a key genomic marker caused by errors in DNA repair. In pancreatic cancer, identifying MSI can directly change treatment plans by making immunotherapy, such as pembrolizumab (Keytruda), an option. MSI testing offers hope for personalized care, providing actionable insights that improve outcomes. Learn how this critical marker is reshaping pancreatic cancer treatment and advancing clinical trials to improve survival rates